ProMetic's press release...Strategic and Financial Benefits of the Transaction: Provides the opportunity for further integration of manufacturing capability and longer term capacity expansion in a 150,000 sq. ft. facility in Belleville, Ontario; Provides approximately $34 million in cash to be deployed towards ProMetics drug development and clinical programs and value generating activities; Does not materially affect ProMetics EBITDA and operating cash flows; Provides up to $50 million in potential tax attributes; and Provides ProMetic with a significant foothold in Ontario, consolidating its presence as a major player in the Canadian market. -- https://www.prometic.com/prometic-announces-agreement-to-acquire-telesta-therapeutics-inc-in-all-share-transaction/ -- $34 mil cash with 303 mil TST shares outstanding. plus, plus. Good to see a press release so others can consider/ reconsider ....